CASE REPORT
Published on 12 Feb 2025
A remarkable and durable response to tislelizumab treatment of an anaplastic thyroid carcinoma without targetable genomic alterations: a case report
doi 10.3389/fimmu.2025.1544604
- 573 views
818
Total downloads
2,617
Total views and downloads
Submit your idea
You will be redirected to our submission process.
CASE REPORT
Published on 12 Feb 2025
MINI REVIEW
Published on 11 Feb 2025
Manuscripts can be submitted to this Research Topic via the main journal or any other participating journal.
Submit your idea
You will be redirected to our submission process.